demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 all comersCOVID-19 mild to moderateCOVID-19 severe or critically
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 mild to moderateCOVID-19 severe or critically
miscellaneous
Aspirin RECOVERY ...
camostat mesilate Gunst JD
Cannabidiol Crippa ...
pyridostigmine Fragoso-Saavedra ...
sabizabulin VERU-111

7 studies excluded by filtering options 0

4960 Ming Zhong, 2020 113high risk of bias
4977 COVID-AIV, 0 000selection pending
5620 Mansour, 0 010selection pending
5841 Mohamed, 2020 110risk of bias not avaialble
5962 de Alencar, 2020 000selection pending
6973 ACTIV-3 Critical Care, 2022 110risk of bias not avaialble
9583 Chow, 2022 0130selection pending